Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ANAPLASMOSIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 379 records · Page 21Linked to original sources
PubMed1978

Immunization against anaplasmosis and babesiosis. Part II. Evaluation of cryo-preserved vaccines using different doses and routes of inoculation.

Anaplasma marginale, Babesia argentina and Babesia bigemina infected blood used as vaccines for immunization trials in Valle del Cauca, were preserved with 4 Molar Dimethyl-Sulfoxide (4M DMSO) and stored in liquid nitrogen (-196 degrees C). The effectivity of the vaccines was determined in 87 healthy calves utilizing serial 10-fold dilutions. The effects of dose, inoculation routes, time and temperature were determined. The minimum infective dose for A. marginale was 10(-3) (2 x 10(6)) when 2 ml of vaccine were given intravenously (i.v.). The same dose when given subcutaneously (s.c.) was not infective. The 10(-2) dilution (2 x 10(7)) was infective when given through both routes, however, the incubation periods were statistically different. The average incubation period using 2 ml s.c. was 30 days, but when the dose was increased to 5 ml and given s.c. the average incubation period decreased to 22 days. The minimum infective doses for b. bigemina and B. argentina were 10(-1) dilutions (4 x 10(-7)) and 10(-2) (4 x 16(6)) respectively, when 2 ml of vaccines were injected i.v.. Infectivity was also recorded when Babesia spp. vaccines were injected s.c. at dosages of 5 ml of dilution 10(-1) (1 x 10(-8)).

Anaplasma↗
PubMed1981

Cell-mediated immune response in anaplasmosis in cattle.

The cell-mediated immune response (CMIR) was demonstrated during experimental Anaplasma marginale infection in cattle, in vivo by the intradermic skin test and in vitro by the leucocyte migration inhibition test (LMIT). The skin test showed a delayed hypersensitivity reaction which reached its maximum after 48-72 hours. Histopathological examination of the skin biopsies revealed excessive infiltration by mononuclear cells and accumulation of oedematous fluid in the deeper dermal layers. For LMIT, the particulate antigen was used and the inhibition of leucocyte migration was significant in vaccinated and carrier animals as compared to controls.

Anaplasmosis↗
PubMed1981

Clinical chemistry of anaplasmosis: blood chemical changes in infected mature cows.

The clinical chemical changes induced by Anaplasma marginale infection were determined in 16 adult, intact cows infected with either of 2 virulent isolates and in 8 others treated with a live sheep-attenuated A marginale vaccine and were compared with the clinical chemical analyses in 7 noninfected controls. Blood samples from the cows were analyzed for various serum components and during clinical disease. Cows infected with the 2 virulent isolates had maximum erythrocyte parasitemias (0.5% to 66%) between 1 and 11 days of patency (DP); 7 of the 16 infected animals died within 5 to 12 DP. Cows given the sheep-attenuated anaplasma vaccine had maximum parasitemias (0.1% to 4.2%) between 1 and 16 DP and none died. Infection with the virulent isolates produced severe anemia (mean RBC count = about 2 million/mm3) and caused increases in serum total bilirubin (TBILI), direct bilirubin (DBILI), serum urea nitrogen (SUN), alkaline phosphatase (ALP), and serum aspartate aminotransferase (AST) that were significantly higher than comparable changes in control values. These increases were highest after peak parasitemias in surviving animals. Vaccination with the attenuated isolate produced a mild anemia (mean RBC count = about 5 million/mm3) and a significant increase only in ALP. Marked increase in TBILI, DBILI, SUN, ALP, and AST were detected 0 to 1 day before death in 3 cows. However, such increases were not observed 2 to 4 days before death in the other cows that died.

Alkaline Phosphatase↗
PubMed1981

Clinical chemistry of anaplasmosis: comparative serum protein changes elicited by attenuated and virulent Anaplasma marginale isolates.

In a comparative study of the clinical chemical changes during Anaplasma marginale infection, 16 intact mature cows were infected with either of 2 virulent isolates. Eight others were treated with a live A marginale vaccine (sheep-attenuated) and 7 were maintained as controls. Before and during patency, samples of blood from the cows were analyzed for total WBC, parasitemia, card test titer (CTT), total protein, albumin, and globulin fractions. In the cows inoculated with virulent isolates, albumin was significantly depressed throughout patency, whereas gamma-globulins and WBC were increased after peak parasitemia, as well as during recovery. The CTT was highest immediately after peak parasitemia. A significant increase was not observed in beta-globulin. Seven of the 16 infected cows died, but no consistent patterns of change in serum protein fractions or WBC could be associated with mortality. The 8 cows vaccinated with the attenuated isolate showed a significant mean decrease in albumin throughout patency, but no significant mean increase in alpha- or beta-globulin. A mean increase in gamma-globulin was observed only during the recovery period. The CTT increased gradually throughout patency, peaking during the recovery period. A significant mean increase over control in WBC count was observed only during rising parasitemia.

Anaplasmosis↗
PubMed1978

Amicarbalide: a therapeutic agent for anaplasmosis.

When administered subcutaneously in 2 equal daily doses at a total dosage rate of 20 mg/kg, amicarbalide was found to be an effective agent for controlling acute infections of Anaplasma marginale and A. centrale in intact and splenectomized cattle. Attempts to sterilize patent and latent Anaplasma infections, however, were unsuccessful. At total dosage rates of 40 mg/kg and higher, amicarbalide exhibited potent hepato- and nephrotoxic tendencies.

Amidines↗
PubMed1989

Seroprevalence of anaplasmosis in the Red River Plains and south-east areas of Louisiana.

The indirect fluorescent antibody test was used to detect antibodies to Anaplasma marginale in serum samples collected from cattle in the Red River Plains and South-east areas of Louisiana. Convenience sampling of herd clusters was used. A reactor rate of 7.8% was found in 11,085 samples. Beef cattle had a 11.2% reactor rate compared with 3.8% for dairy cattle. The Angus and Angus cross-breed group had the highest reactor rate.

Age Factors↗
PubMed2006

New findings on anaplasmosis caused by infection with Anaplasma phagocytophilum.

Ixodes ricinus (I. ricinus) is one of the vectors of Anaplasma phagocytophilum (A. phagocytophilum) in Europe, in which rates of infection range from 1.9% to 34%. In 1998, human granulocytic ehrlichiosis-like (HGE-like) Ehrlichia DNA was detected in Italy, by PCR technique in one I. ricinus nymph out of 55 ticks that were examined. In 1996, 6.3% of 310 human sera in high-risk subjects from Italy were found positive for antibodies to Ehrlichia phagocytophila (E. phagocytophila). In the same year, the authors reported the first case of equine granulocytic ehrlichiosis. In 1997, only 2 out of 563 equine blood samples examined were found positive for antibodies to E. phagocytophila in the Latium region. In 1998, serological positivity was not observed in 14 symptomatic race horses. In 2002, a symptomatic horse living in Rome was found positive for Ehrlichia equi (E. equi) antibodies, as confirmed by PCR. E. equi was also demonstrated in horses by detection of specific antibodies from two asymptomatic ponies. We tested 128 sera from sheep in different flocks, and antibodies to E. phagocytophila were detected in 17 sera (13.3%) of these sheep. From 2000 to 2004, 147 dog sera were tested for antibodies against A. phagocytophilum, and 7 of these sera were positive (4.8%). These data confirm the presence of the infection in human, domestic animals, and pets in Italy. Studies are under way to correlate the distributions of the disease and tick vector, I. ricinus.

Anaplasma phagocytophilum↗
PubMed2006

Molecular diagnosis of granulocytic anaplasmosis and infectious cyclic thrombocytopenia by PCR-RFLP.

Anaplasma phagocytophilum (A. phagocytophilum, formerly Ehrlichia phagocytophila) is a tick-borne pathogen responsible for tick-borne fever in ruminants, equine granulocytic ehrlichiosis (EGE) in horses, canine granulocytic ehrlichiosis (CGE) in dogs, and for human granulocytic ehrlichiosis (HGE). Human cases have been registered in many countries with a broad range of symptoms and pathogenicity. This article focused on Sardinia as the prevalence in humans was almost seven times higher than in the rest of Italy. To evaluate the risk, blood samples were collected from dogs and horses on the island. Genomic DNA was extracted from the buffy coat and amplified by heminested polymerase chain reaction (PCR) using the groEL gene primers. The first PCR reaction amplified a 624-bp fragment for both A. phagocytophilum and A. platys while the second PCR reaction amplified 573-bp and 515-bp fragments for the above two pathogens, respectively. Six A. phagocytophilum samples were PCR positive (3 dogs and 3 horses) while another dog was A. platys PCR positive. A phylogenetic analysis was conducted with A. phagocytophilum sequences in GenBank from the United States, Slovenia, Switzerland, Germany, UK, Austria, and Czech Republic. Surprisingly, the related phylogenetic tree showed that the Sardinian isolates were closer to the American isolates, which were showing highest mortality rates than from the other two European lineages.

Anaplasma phagocytophilum↗